{"id":"W4322772104","doi":"10.1158/1538-7445.sabcs22-ot1-01-01","title":"Abstract OT1-01-01: A randomised phase II trial of palbociclib and fulvestrant vs standard endocrine therapy in patients with ER positive HER2 negative breast cancer and ctDNA detected molecular relapse during adjuvant endocrine therapy (TRAK-ER)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Fulvestrant; Palbociclib; Medicine; Oncology; Breast cancer; Internal medicine; Tamoxifen; Cancer; Estrogen receptor; Gynecology; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005650248,0.0005070029,0.001122936,0.0006401296,0.000240809,0.00004353309,0.0001935726,0.0001072927,0.000300265],"category_scores_gemma":[0.0001126717,0.0003821311,0.0001177501,0.001282669,0.0009039721,0.0002917965,0.000112448,0.0009251368,0.000001161646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004850392,"about_ca_system_score_gemma":0.0006509501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002067582,"about_ca_topic_score_gemma":0.0004613495,"domain_scores_codex":[0.9956768,0.0003206144,0.0006792131,0.0008970585,0.001341606,0.001084734],"domain_scores_gemma":[0.9977614,0.0003997228,0.0002426003,0.0004677399,0.0007462041,0.0003823619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7654061,0.0008191662,0.008061619,0.0002021493,0.0007195722,0.0004149725,0.003281409,0.00005982195,0.1437994,0.000005544217,0.00001320626,0.07721705],"study_design_scores_gemma":[0.5240258,0.006835414,0.3122884,0.0009038959,0.00004273318,0.00002876374,0.0004140056,0.00001746452,0.1549059,0.0001143709,0.00008465954,0.0003385407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892784,0.002948126,0.000008770118,0.001350026,0.00008990891,0.005344138,0.0008664076,0.00008686641,0.00002734286],"genre_scores_gemma":[0.9888157,0.009201488,0.0000785381,0.00007335835,0.000163395,0.001393856,0.00005227082,0.0001361777,0.00008521936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3042268,"threshold_uncertainty_score":0.9998631,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02302692500365251,"score_gpt":0.3602571496629208,"score_spread":0.3372302246592683,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}